4//SEC Filing
ACORDA THERAPEUTICS INC 4
Accession 0001209191-15-081690
CIK 0001008848operating
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 8:01 AM ET
Size
8.7 KB
Accession
0001209191-15-081690
Insider Transaction Report
Form 4
Blight Andrew
Chief Scientifc Officer
Transactions
- Sale
Common Stock
2015-11-20$37.47/sh−500$18,735→ 71,659 total - Exercise/Conversion
Common Stock
2015-11-20$8.50/sh+500$4,250→ 72,159 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-11-20−500→ 0 totalExercise: $8.50Exp: 2016-09-25→ Common Stock (500 underlying)
Footnotes (2)
- [F1]Exercises and sales pursuant to a 10b5-1 Plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
- [F2]The shares subject to these options vested in installments and were fully vested on 9/25/2010.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001008848
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 8:01 AM ET
- Size
- 8.7 KB